Dendreon ON Call

Your reimbursement and patient support resource for PROVENGE is now online!

Dendreon ON Call provides a variety of comprehensive and convenient services and resources to help facilitate treatment with PROVENGE, including reimbursement support, patient assistance programs, referrals to independent foundations for financial assistance, and product ordering.

To utilize our support services, simply visit Dendreon ON Call online, or call 1-877-336-3736.

Enroll Your Patients
To start treatment with PROVENGE, physicians must complete Patient Enrollment through Dendreon ON Call.
Enroll Patients Online | Download the Enrollment Form (English PDF | PDF español) | Contact Dendreon ON Call at 1-877-336-3736.

Comprehensive Reimbursement Support
Dendreon ON Call provides you with comprehensive and convenient reimbursement services and product support. Our fast, secure online services are open 24/7, or contact our coordinators at 1-877-336-3736, to assist you.

Did You Know: Dendreon ON Call provides timely information to help expedite patient access to care. In fact, most reimbursement research requests can be completed in 1 to 2 business days from the time complete information is submitted to Dendreon ON Call.*

Dedicated case managers provide resources and referrals for patients requiring help:

Government Programs Patients Insured Through Government Programs (e.g. Medicare)

  • A reimbursement coordinator can refer your patients to an independent foundation that provides financial assistance for co-pays, co-insurance, and deductible costs
  • Eligibility is determined by the independent foundation

Commercial Health Plans Patients Insured Through Commercial Health Plans

  • Patients may be eligible to access PROvide, the PROVENGE commercial co-pay program that provides financial assistance for co-pays, co-insurance, and deductible costs
  • Eligibility criteria include:
    • A household adjusted gross income of $150,000 or less
    • United States residence
    • On-label prescription for PROVENGE
    • Patient has private commercial health insurance§

Support for Patients Without Coverage Support for Patients Without Coverage for PROVENGE

  • For eligible patients who do not have coverage for PROVENGE, Dendreon provides drug free of cost
  • In the event an eligible patient's claim for coverage for PROVENGE is denied by his payer after all appeals, the cost of the drug may be covered by Dendreon's patient assistance program
  • Eligibility criteria include:
    • A household adjusted gross income of $150,000 or less
    • United States residence
    • On-label prescription for PROVENGE

Travel Cost Assistance Travel Cost Assistance

  • Program applies to both Medicare and commercially insured patients
  • Eligibility is determined by the individual foundation

When a patient begins therapy with PROVENGE, dedicated case managers will work with your office throughout therapy to handle logistics and product support, including:

  • Generating individualized patient schedules (leukapheresis and infusion appointments)
  • Reminding patients about appointments
  • Providing Product Ordering, Delivery, and Returns Support

Dendreon also facilitates extended payment terms for PROVENGE. || Download the application.

*Most benefits verification summaries are communicated within 2 business days after Dendreon ON Call receives complete paperwork. Any missing information may extend the turnaround time.

Co-pay and travel assistance foundations provide assistance regardless of the choice of medicine, and decisions are based on financial need and according to criteria established by individual foundations. Dendreon ON Call can assist patients by referring them to these independent organizations. Dendreon cannot guarantee that patients will be eligible for or receive assistance after referral. Dendreon does not have controlling or managerial influence on these independent organizations.

PROvide, the commercial co-pay card program, and the Uninsured Patient Program eligibility criteria can be changed or program can be discontinued at any time at the sole discretion of Dendreon.

§Patients with government-funded insurance including Medicare, Medicare Part D, Medicaid, or TriCare are not eligible.

|| Services vary by office based on application criteria and are subject to change or discontinuation.

Our Distribution Partners

PROVENGE is now available from:

McKesson, AmerisourceBergen Corporation/Oncology Supply, Cardinal Health

Onmark, US Oncology, VitalSource, ION GPO

Extended Payment Terms are provided through your distributor.

INDICATION

PROVENGE® (sipuleucel-T) is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

IMPORTANT SAFETY INFORMATION

Acute Infusion Reactions: Acute infusion reactions (reported within 1 day of infusion) may occur and include nausea, vomiting, fatigue, fever, rigor or chills, respiratory events (dyspnea, hypoxia, and bronchospasm), syncope, hypotension, hypertension, and tachycardia. Closely monitor patients with cardiac or pulmonary conditions.

Thromboembolic events: Thromboembolic events, including deep venous thrombosis and pulmonary embolism, can occur following infusion of PROVENGE. The clinical significance and causal relationship are uncertain. Most patients had multiple risk factors for these events. PROVENGE should be used with caution in patients with risk factors for thromboembolic events.

Vascular disorders: Cerebrovascular events (hemorrhagic/ischemic strokes and transient ischemic attacks) and cardiovascular disorders (myocardial infarctions) have been reported following infusion of PROVENGE. The clinical significance and causal relationship are uncertain. Most patients had multiple risk factors for these events.

Handling Precautions: PROVENGE is intended solely for autologous use and is not tested for transmissible infectious diseases.

Adverse Reactions: The most common adverse reactions reported in clinical trials (≥ 15% of patients receiving PROVENGE) were chills, fatigue, fever, back pain, nausea, joint ache, and headache.

Please see the Full Prescribing Information.

Full Prescribing Information